New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareChonluten vs Tripeptide-29

Chonluten vs Tripeptide-29

Side-by-side comparison of key properties, dosing, and research.

Anti-Aging & Longevity
Chonluten
Skin & CosmeticAnti-Aging & Longevity
Tripeptide-29
Summary
Chonluten is a tripeptide bioregulator (Glu-Asp-Leu) developed by Professor Vladimir Khavinson, tissue-specific to the bronchi and lungs. While related to Bronchogen (a tetrapeptide), Chonluten is a shorter tripeptide sequence. It supports bronchial mucosal cell function, promotes respiratory epithelial regeneration, and is used in protocols for COPD, chronic bronchitis, and pulmonary anti-aging.
Tripeptide-29 is a pro-collagen cosmetic peptide composed of proline, hydroxyproline, and glycine — the core repeating unit of collagen. Applied topically, it signals dermal fibroblasts that collagen degradation has occurred, triggering compensatory new collagen synthesis.
Half-Life
Short (minutes for the peptide); sustained gene-regulatory effects
Not applicable (topical)
Admin Route
SubQ, Oral
Topical
Research
Typical Dose
10 mg per day
0.01-0.1% in formulation
Frequency
Daily for 10–30 days
Once or twice daily
Key Benefits
  • Supports bronchial mucosal regeneration and repair
  • May improve mucociliary clearance in chronic respiratory conditions
  • Anti-inflammatory effects on bronchial epithelium
  • Pulmonary anti-aging and tissue preservation
  • Supports lung function in COPD and chronic bronchitis
  • Well tolerated in combination with other Khavinson bioregulators
  • Short tripeptide with efficient cellular penetration
  • Stimulates fibroblast collagen synthesis via damage-signal mechanism
  • Reduces fine lines and improves skin smoothness
  • Supports dermal matrix integrity
  • Naturally bioidentical to collagen fragment sequences
  • Well-tolerated in all skin types
  • Synergistic with copper peptides and retinoids
Side Effects
  • Generally well tolerated
  • Mild injection site reactions possible
  • No significant adverse pulmonary events reported
  • Excellent tolerability profile
  • No documented significant adverse effects at cosmetic concentrations
  • Rare sensitivity reactions in individuals with peptide allergies
Stacks With